je.st
news
Home
› AstraZeneca Enters Into An Agreement With IntelliCyt For The Development Of High Throughput Biology Applications
AstraZeneca Enters Into An Agreement With IntelliCyt For The Development Of High Throughput Biology Applications
2016-06-01 06:19:16| drugdiscoveryonline Home Page
IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery,antibody discovery and immuno-oncology research today announced a collaboration with AstraZeneca to further the development of high throughput biology applications to provide insights into the complex biology of disease
Tags: high
development
agreement
applications
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||